<ѻý>FDA Panel Rejects SGLT1/2 Inhibitor for Type 1 Diabetesѻý> Data too uncertain to support sotagliflozin in subset with chronic kidney disease, advisors say Nov 01, 2024
<ѻý>RFK Jr. Wants Access to Federal Data to Show Vaccines Are Unsafe, Trump Advisor Saysѻý> Goal is to get vaccines pulled from the market, according to Trump transition leader Nov 01, 2024
<ѻý>Old Drugs, New Tricks: The Power of Medication Repurposingѻý> COVID highlighted the untapped potential of existing treatments Oct 30, 2024
<ѻý>IG Live November 1: Healthcare Is on the Ballotѻý> Public health and access to care are at stake in the 2024 election Oct 30, 2024
<ѻý>Could RFK Jr. Really Become HHS Secretary?ѻý> It seems unlikely, but Washington insiders say they've come to expect the unexpected Oct 29, 2024
<ѻý>AirPods' Hearing Aid Feature Could Help People Face a Problem They'd Rather Ignoreѻý> Apple's new feature can boost voices, media, and phone calls, and maybe lessen stigma Oct 29, 2024
<ѻý>A Look at the Supreme Court's Upcoming Termѻý> Public health is on the chopping block once again Oct 28, 2024
<ѻý>FDA Approves Novel Treatment for UTIsѻý> New oral antibiotic gets a nod for uncomplicated urinary tract infections Oct 25, 2024
<ѻý>Ob/Gyn Attack Caught on Tape; Antidepressant Recall; Onions Eyed as E. Coli Sourceѻý> Health news and commentary gathered by ѻý staff Oct 25, 2024
<ѻý>FDA Warns Companies Over Products Made With Amniotic Fluidѻý> Agency says PalinGen products are unapproved drugs Oct 24, 2024
<ѻý>Approval of Bevacizumab Biosimilar for Ophthalmic Use Could Upend Low-Cost Anti-VEGFѻý> Provision in drug act would prohibit repackaging Avastin, add millions to anti-VEGF therapy cost Oct 24, 2024
<ѻý>FDA Expands Approval of RSV Vaccine Abrysvo to Include All At-Risk Adultsѻý> Decision was based on need for RSV protection in younger people with chronic conditions Oct 23, 2024
<ѻý>What Will the IV Fluid Shortage Mean for Hospital Finance?ѻý> A more strategic approach to production is key to preventing crises like this Oct 23, 2024
<ѻý>Novel Targeted Drug Approved for Stomach Cancersѻý> Zolbetuximab indicated alongside fluoropyrimidine- and platinum-containing chemotherapy Oct 18, 2024
<ѻý>Drugmaker Pulls Trodelvy's Bladder Cancer Approvalѻý> In confirmatory trial, antibody-drug conjugate failed to improve OS versus chemotherapy Oct 18, 2024
<ѻý>Serious Battery Issue Prompts Medtronic Insulin Pump Recallѻý> Problem linked to 170 reports of hyperglycemia and 11 ketoacidosis cases Oct 18, 2024
<ѻý>Continuous Parkinson's Disease Therapy Wins FDA Nodѻý> Round-the-clock infusion delivers carbidopa and levodopa pro-drugs Oct 17, 2024
<ѻý>Three States Renew Effort to Reduce Access to Abortion Pill Mifepristoneѻý> Lawsuit aims to require three in-person doctor visits, bar drug's use after 7 weeks of pregnancy Oct 17, 2024
<ѻý>The Supreme Court's Open Season on Public Health Agenciesѻý> "I just had this reverence for the court. I don't anymore," says Lawrence Gostin, JD Oct 16, 2024 video
<ѻý>Poppy Seed Brew Triggers Morphine Overdose, Drawing Attention of Lawmakersѻý> During harvesting and processing, the seeds can become coated with the opium Oct 12, 2024
<ѻý>Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitorsѻý> First once-weekly subcutaneous prophylactic option for hemophilia B Oct 11, 2024
<ѻý>Elamipretide for Barth Syndrome Survives FDA Advisory Voteѻý> Panelists acknowledge difficulty generating stronger data in ultra-rare disease Oct 11, 2024
<ѻý>PI3K Inhibitor Wins FDA Approval for Advanced Breast Cancerѻý> Adding inavolisib to palbociclib/fulvestrant more than doubled PFS in endocrine-resistant disease Oct 10, 2024
<ѻý>FDA's Promised Guidance on Pulse Oximeters Unlikely to End Decades of Racial Biasѻý> Devices three times as likely to miss dangerously low blood oxygen in Black patients Oct 10, 2024
<ѻý>FDA Reviewers Cast Doubt on Drug Candidate for Barth Syndromeѻý> Agency appears unswayed by mitochondria-targeting drug for rare cardioskeletal disease Oct 09, 2024
<ѻý>How Did Public Health Become a Public Enemy at the Supreme Court?ѻý> Conservative majority is "buying into" anti-science attitudes, warns Lawrence Gostin, JD Oct 09, 2024 video
<ѻý>Should I Prescribe Liraglutide to a 6-Year-Old Patient With Obesity if FDA Approved?ѻý> I anticipate benefits outweighing potential risks in only a select few situations Oct 06, 2024
<ѻý>Judge Rules Against Stem Cell Clinicѻý> Two federal court decisions now hold that fat-derived stem cell treatment is a drug Oct 02, 2024
<ѻý>Elevating Family Medicine Is Key for New AAFP Presidentѻý> Jen Brull, MD, outlines her priorities for the coming year Oct 01, 2024
<ѻý>No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Saysѻý> Despite problematic dataset, risk/benefit profile not favorable with PD-L1 expression below 1 Sep 27, 2024
<ѻý>First-Ever Biologic Approved for COPDѻý> Phase III trial program showed 30% to 34% reduction in moderate or severe exacerbations Sep 27, 2024
<ѻý>FDA Approves First Novel Drug for Schizophrenia in Decadesѻý> Xanomeline and trospium chloride (Cobenfy) has no boxed warnings Sep 27, 2024
<ѻý>Sickle Cell Disease Drug Pulled From Global Marketsѻý> Benefits of voxelotor (Oxbryta) no longer outweigh the risks, Pfizer says Sep 26, 2024
<ѻý>FDA Expands Approval of Osimertinib in Lung Cancerѻý> EGFR inhibitor now indicated for unresectable stage III disease following chemoradiotherapy Sep 25, 2024
<ѻý>Second Drug OK'd for Ultra-Rare Neurodegenerative Diseaseѻý> FDA approves levacetylleucine (Aqneursa) for Niemann-Pick disease type C Sep 25, 2024
<ѻý>IG Live September 27: Court Adjourned, Healthcare Overturnedѻý> Decoding recent SCOTUS decisions and their potential impact on healthcare Sep 25, 2024
<ѻý>Immunotherapy May Not Benefit All Gastroesophageal Cancer Patients, FDA Staff Saysѻý> Data since approvals suggest benefits limited to subgroups with PD-L1 expression of at least 1% Sep 24, 2024
<ѻý>FDA OKs First Flu Vaccine for At-Home Useѻý> FluMist nasal spray can now be used without the help of a healthcare provider Sep 20, 2024
<ѻý>First Drug Approved for Niemann-Pick Disease Type Cѻý> Arimoclomol (Miplyffa) greenlit for ultra-rare genetic disorder Sep 20, 2024
<ѻý>FDA Rejects NK1R Antagonist for Gastroparesisѻý> Drugmaker none-too-pleased with agency's request for additional studies Sep 19, 2024